Bioengineered plants meet vaccines. It actually is a lot more promising than it may sound. A pioneer in the field is Arizona State University Professor Charles Arntzen. He has been working on nothing less than the world’s most promising anti-Ebola drug. ZMapp is an injectable synthetic serum made of genetically engineered antibodies grown in tobacco plants. The technology could be used to combat other infectious diseases and lower the cost of expensive drugs used to fight cancer, HIV, and other chronic health conditions. The story of Pr. Arntzen and his Ebola project reads like a thriller script. We hope you enjoy it as we have.
Meet Charles Arntzen, creator of world’s most promising anti-Ebola drug from tobacco plants
More of Today's Solutions
Europe removed a record 602 river barriers last year
BY THE OPTIMIST DAILY EDITORIAL TEAM A dam fell in Iceland last December, the first the country has ever deliberately dismantled. The structure on ...
Read MoreThis ultrasonic espresso method uses 75 percent less energy and tastes just a...
BY THE OPTIMIST DAILY EDITORIAL TEAM So many of us participate in the same morning coffee ritual: the machine warming up, the pressure building, ...
Read MoreMexico’s tequila fish brought back from the brink of extinction
Mexico’s tiny tequila splitfin fish was once a common inhabitant in the country’s Teuchitlán river in the western part of the country. But due ...
Read MoreHow Bogotá is tackling air pollution by greening its poorest neighborhoods
BY THE OPTIMIST DAILY EDITORIAL TEAM In Bogotá, Colombia’s bustling capital, the battle against air pollution isn’t just about cleaner skies. It’s about equity. ...
Read More
